Daclarise Plus is a generic brand that contains Daclatasvir 60 mg and Sofosbuvir 400 mg, antivirals for the Hepatitis B virus. The mechanism of action involves reducing the Hepatitis B infection load in the body and gradually eliminating the virus from the blood. HCV infection is now widespread worldwide. Hepatitis C-induced liver damage impacts the body through both acute and long-term inflammation. The pathogens spread through contact with sperm, blood, bodily fluids, and human infection. Additionally, it can spread via needle sharing or mother-to-child transmission. Cirrhosis, liver cancer, and liver damage can occasionally result from this illness.
Hepatitis C symptoms can appear before or after infection. Loss of appetite, exhaustion, fever, jaundice, weakness, joint pain, nausea, vomiting, muscular pains, and dark urine are some of these symptoms. It is important to take these symptoms seriously due to the high risk of liver damage. Regular blood tests, health checkups, and prompt treatment at the first sign of symptoms are essential. This illness negatively affects the body and can cause widespread weakness. In order to lower the viral load of the virus, extra care must be taken to lessen the impact of symptoms on the body. An essential component of the body's operation is the liver.
Antiviral Products Manufacturer In IndiaDaclarise Plus Contains Daclatasvir and Sofosbuvir, which function independently in the body and according to need, are usually included. Daclatasvir's mechanism of action is as an antiviral that inhibits or reduces the HCV infection nonstructural protein 5A. This combination disrupts ribonucleic acid replication and virion assembly, stopping the infection’s progression.
In the meanwhile, the hepatitis C infection NS5B RNA-dependent RNA polymerase, which is essential for viral replication, is inhibit by the nucleotide analog sofosbuvir. This reduces the body's viral burden and inhibits the virus from reproducing. Sunrise Remedies Pvt. Ltd. is a manufacturer of HIV, antiretroviral, and hepatitis B viral generics.
Daclatasvir 60 mg and Sofosbuvir IP 400 mg.
Indicated for the treatment of chronic hepatitis C (CHC) in adults.
Always take Advise from Your Doctor*